Shield Therapeutics PLC (STX) RNS Announcements

Date	Time	Date	TitleTitle (filtered)
04/02/22	07:00:04	4 Feb 2022	KOL Investor Event on Iron Deficiency	KOL Investor Event on Iron Deficiency
07/01/22	07:00:07	7 Jan 2022	Investor Presentation	Investor Presentation
05/01/22	07:00:08	5 Jan 2022	Licence Agreement in Canada for Accrufer®	Licence Agreement in Canada for Accrufer®
30/12/21	09:06:12	30 Dec 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
30/12/21	09:00:55	30 Dec 2021	Price Monitoring Extension	Price Monitoring Extension
29/12/21	11:05:44	29 Dec 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
29/12/21	11:00:40	29 Dec 2021	Price Monitoring Extension	Price Monitoring Extension
16/12/21	11:05:51	16 Dec 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
16/12/21	11:00:49	16 Dec 2021	Price Monitoring Extension	Price Monitoring Extension
16/12/21	07:00:04	16 Dec 2021	Patient Access Expands for Accrufer®	Patient Access Expands for Accrufer®
30/09/21	17:30:05	30 Sept 2021	Block Listing 6 Monthly Return	Block Listing 6 Monthly Return
27/09/21	07:00:07	27 Sept 2021	Jose A. Menoyo Appointed as Chief Medical Officer	Jose A. Menoyo Appointed as Chief Medical Officer
21/09/21	07:00:11	21 Sept 2021	Investor presentation	Investor presentation
23/08/21	07:00:05	23 Aug 2021	PDMR Transaction Notification	PDMR Transaction Notification
17/08/21	07:00:03	17 Aug 2021	Half-year Report	Half-year Report

Showing 201–215 of 215 announcements

Shield Therapeutics PLC RNS